NASDAQFinancialsFinancial ConglomeratesSnapshot 2026-07-31
Reading TREE? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Adjusted EBITDA for 2026 between $152 million and $162 million: metric not reported.
View ThesisRevenue is growing steadily — about 24% over the past year.
View GrowthManagement screens weak on capital allocation, earnings delivery, margins, market reaction to earnings.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 59% in its worst 12-month stretch.
View RiskTREE's growth relies on its ability to recover the small business loan segment. The company aims for a 45%-50% adjusted EBITDA-to-VMD goal as SMB recovers. Recent earnings showed a 25% year-over-year revenue growth, but the last quarter missed expectations. It trades at 8.5× P/E, below the peer median of 12.2×. This suggests the price reflects modest growth expectations. A specific risk is the 39% chance of missing the next quarter's earnings. Peer multiples imply a price about 48% above where it trades. This read is provisional.
Trailing returns as of 2026-07-31. TREE is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 6 analysts currently covering TREE (as of Jul 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A consensus fair price across 9 valuation methods, at three horizons. As of 2026-08-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Financials (broad) — fair value, gap to price, and forward P/E.
Advances: Grow revenue and segment profit, led by Insurance segment
Insurance segment growth offsets SMB challenges.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-31. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Stabilize and grow small business (SMB) loan segment
SMB recovery goal directly supports growth objectives.
Threatens: Maintain adjusted EBITDA guidance for 2026
Q2 2026 EPS miss impacts revenue guidance.
Threatens: Increase revenue guidance for 2026
Missed revenue estimates affect growth outlook.
Positive analysis supports LendingTree's valuation amidst leadership changes.
Executive involvement in AI roadmap enhances company profile.
Strong Q1 earnings indicate potential for increased revenue guidance.
Strong insurance growth suggests positive future revenue trends.
